TGFA and cervical squamous cell carcinoma: As a consequence, TGFA can be employed as an independent risk factor for CESC as well as a feasible molecular marker for CESC diagnosis, therapy, and prognosis prediction, allowing doctors to build a more personalized treatment plan for their patients.